Literature DB >> 33871198

Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.

Eduardo Garzón1, John Jairo Dávila-Rodríguez2.   

Abstract

We report the clinical and histopathological features of hydroa vacciniforme-like lymphoproliferative disorder in five indigenous and Mestizo children. All the children resided at higher altitudes, experiencing maximal solar exposure. All cases presented with prurigo along with Epstein-Barr virus infection. Histopathologic examination showed an atypical, CD30 + lymphocytic infiltrate with angiocentricity in all, while three cases demonstrated panniculitis-like infiltrate.

Entities:  

Keywords:  Cutaneous lymphoma; Epstein–Barr virus; hydroa vacciniforme

Year:  2021        PMID： 33871198     DOI： 10.25259/IJDVL_847_19

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


  10 in total

1.  Clinicopathological analysis of the hydroa vacciniforme-like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T-cell lymphoma.

Authors:  Guan-Nan Wang; Yong Cui; Wu-Gan Zhao; Ling Li; Xu-Dong Zhang; Yu Chang; Xian-Zheng Gao; Ye Li; Ming-Zhi Zhang; Wen-Cai Li
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

Review 2.  Hydroa Vacciniforme-Like Lymphoma in Tibetan Children: 2 Cases and a Literature Review.

Authors:  Xiaoyan Zhang; Tingting Wang; Lin Wang
Journal:  Am J Dermatopathol       Date:  2018-05       Impact factor: 1.533

3.  Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru.

Authors:  Brady E Beltrán; Iván Maza; Celia B Moisés-Alfaro; Liliana Vasquez; Pilar Quiñones; Domingo Morales; Gadwin Sánchez; Gloria Paredes; Mónica Oscanoa; Jenny Gerónimo; Roberto N Miranda; Jorge J Castillo
Journal:  Am J Hematol       Date:  2014-09-26       Impact factor: 10.047

4.  Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.

Authors:  Rosana Ruiz; Zaida Morante; Raul Mantilla; Luis Mas; Luis Casanova; Henry L Gomez
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

5.  Hydroa Vacciniforme-Like T-Cell Lymphoma: A Further Brazilian Case.

Authors:  Mario Fernando Ribeiro de Miranda; Josie Eiras Bisi Dos Santos; Silvia Ferreira Rodrigues Müller; Maraya de Jesus Semblano Bittencourt; Arival Cardoso de Brito; Jorge Nazareno da Silva Barros Junior; Ellen Maria Sampaio Xerfan
Journal:  Am J Dermatopathol       Date:  2018-03       Impact factor: 1.533

6.  Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases.

Authors:  Martin Sangueza; Jose Antonio Plaza
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

7.  Clinicopathologic Features of Hydroa Vacciniforme-Like Lymphoma: A Series of 9 Patients.

Authors:  Mario Magaña; Cesare Massone; Pablo Magaña; Lorenzo Cerroni
Journal:  Am J Dermatopathol       Date:  2016-01       Impact factor: 1.533

8.  Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.

Authors:  Leticia Quintanilla-Martinez; Cecilia Ridaura; Florian Nagl; Marimar Sáez-de-Ocariz; Carola Durán-McKinster; Ramon Ruiz-Maldonado; Georgia Alderete; Peter Grube; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

9.  Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.

Authors:  Jose A Plaza; Martin Sangueza
Journal:  Am J Dermatopathol       Date:  2015-01       Impact factor: 1.533

10.  Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.

Authors:  Jingyi Li; Yiheng Zan; Hongjie Liu; Hanmin Liu; Lina Chen
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.